Adrenal suppression and osteoporosis after treatment of nasal polyposis

Acta Oto-Laryngologica

Volumn 126, Issue 11, 2006, Pages 1195-1200

  Bonfils, Pierre ^a   Halimi, Philippe ^a   Malinvaud, David ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Adrenal insufficiency; Beclomethasone; Nasal polyposis; Osteoporosis; Steroid; Synacthen test; X ray absorptiometry

Indexed keywords

ACETYLSALICYLIC ACID; BECLOMETASONE; PREDNISOLONE; STEROID; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; ADULT; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LUMBAR SPINE; MALE; NOSE POLYP; OSTEOPOROSIS; PRIORITY JOURNAL; SIDE EFFECT;

ABSORPTIOMETRY, PHOTON; ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BONE DENSITY; DENSITOMETRY, X-RAY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; LONG-TERM CARE; MALE; MIDDLE AGED; NASAL POLYPS; OSTEOPOROSIS;

EID: 33750090377     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480600672667     Document Type: Article

References (16)

1. Radenne F, Lamblin C, Vandezande LM, Tillie-Leblond I, Darras J, Tonnel AB, et al. Quality of life in nasal polyposis. J Allergy Clin Immunol 1999;104:79-84.
2. Larsen PL, Tos M. Origin and structure of nasal polyps. In: Mygind N, Lilholdt T, editors. Nasal polyposis: an inflammatory disease and its treatment. Copenhagen: Munksgaard; 1997. p. 17-30.
3. Bonfils P, Norès JM, Halimi P, Avan P. Corticosteroid treatment in nasal polyposis with a three-year follow-up period. Laryngoscope 2003;113:683-7.
4. Mygind N. Advances in the medical treatment of nasal polyps. Allergy 1999;54(Suppl 53):12-6.
5. Reynolds RM, Dennison EM, Walker BR, Syddall HE, Wood PJ, Andrew R, et al. Cortisol secretion and rate of bone loss in a population-based cohort of elderly men and women. Calcif Tissue Int 2005;7:134-8.
6. Khosla S, Lufkin EG, Hodgson SF, Fitzpatrick LA, Melton LJ III. Epidemiology and clinical features of osteoporosis in young individuals. Bone 1994;15:551-5.
7. Oelkers W. Adrenal insufficiency. N Engl J Med 1996;335: 1206-12.
8. Dorin RI, Qualls CR, Crapo LM. Diagnosis of adrenal insufficiency. Ann Intern Med 2003;139:194-204.
9. Walsh LJ, Wong CA, Pringle M, Tattersfield AE. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 1996; 313:344-6.
10. Manolagas SC, Weinstein RS. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999;14:1061-9.
11. Bonfils P, Avan P. Non-specific bronchial hyperresponsiveness is a risk factor for steroid insensitivity in nasal polyposis. Acta Otolaryngol 2004;124:290-6.
12. Melton LJ III, Atkinson EJ, O'Fallon WM, Wahner HW, Riggs BL. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 1993;8: 1227-33.
13. Dalen N, Hellstrom LG, Jacobson B. Bone mineral content and mechanical strength of the femoral neck. Acta Orthop Scand 1976;47:503-8.
14. Cummings SR, Marcus R, Palermo L, Ensrud KE, Genant HK and the study of osteoporotic fractures research group. Does estimating volumetric bone density of the femoral neck improve the prediction of fracture? A prospective study. J Bone Miner Res 1994;9:1429-32.
15. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002;359:1929-36.
16. Patel RS, Shaw SR, McIntyre HE, McGarry GW, Wallace AM. Morning salivary cortisol versus short Synacthen test as a test of adrenal suppression. Ann Clin Biochem 2004;41: 408-10.